Clinical Trial Update: A Multicenter Real-life Study of Disseminated Borreliosis Cases Occurring in Patients Receiving Anti-CD20 Treatment in France

View source ↗

Summary

This multicenter French trial investigates disseminated Borrelia infections (Lyme disease) in patients treated with anti-CD20 therapies; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lyme Disease

Drugs mentioned

• Anti-CD20 monoclonal antibody therapy (anti-CD20 monoclonal antibodies)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Borrelia Infections | Status: RECRUITING